Public Health Laboratory Ivo de Carneri
12
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
25%
3 trials in Phase 3/4
50%
5 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
Role: collaborator
Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC
Role: collaborator
Performance of Tests for Schistosoma Haematobium Diagnosis
Role: collaborator
Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC
Role: collaborator
Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura
Role: collaborator
Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration
Role: collaborator
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm
Role: collaborator
Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm
Role: collaborator
Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm
Role: collaborator
NEO-study, Newborn Emergency Outcome
Role: collaborator
Efficacy and Safety of a Multi-dose Regimen of Mebendazole Against Hookworm in Children
Role: collaborator
Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris Trichiura
Role: collaborator
All 12 trials loaded